Table 2.

Treatment course details

	N (range)
Median number of cycles during induction	6 (1-6)
	N (%)
Patients who completed 6 cycles of DA-EPOCH-R	29 (76.3)
Patients with DA-EPOCH dose escalation	25 (65.8)
Patients with ixazomib dose reduction during induction	2 (5.3)
Patients with discontinuation of ixazomib during induction	10 (26.3)
Patients who received maintenance	21 (58.3)
Patients with ixazomib dose reduction during maintenance	5 (13.9)
Patients with discontinuation of ixazomib during maintenance	9 (25)
	N (range)
Median number of cycles during maintenance	5 (1-13)